Page last updated: 2024-11-07

metaraminol and Syndrome

metaraminol has been researched along with Syndrome in 2 studies

Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.

Syndrome: A characteristic symptom complex.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sicuteri, F1
Anselmi, B1
Del Bianco, PL1
Steiner, JA1
Low, PA1
Huang, CY1
West, M1
Uther, JB1
Allsop, JL1
Chalmers, JP1

Other Studies

2 other studies available for metaraminol and Syndrome

ArticleYear
5-hydroxytryptamine supersensitivity as a new theory of headache and central pain: a clinical pharmacological approach with p-chlorophenylalanine.
    Psychopharmacologia, 1973, Volume: 29, Issue:4

    Topics: Brain Chemistry; Drug Hypersensitivity; Fenclonine; Headache; Humans; Lysergic Acid Diethylamide; Me

1973
L-dopa and the Shy-Drager syndrome.
    The Medical journal of Australia, 1974, Jul-27, Volume: 2, Issue:4

    Topics: Blood Pressure; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fecal Incontinence; Flu

1974